推进癌症治疗:针对DNA损伤反应的新前沿
Jiekun Qian1,2, Guoliang Liao1,3, Maohui Chen1,3
1Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Frontiers in pharmacology
|October 7, 2024
概括
针对癌症的向性治疗
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 基因组不稳定性是癌症的标志,由DNA损伤反应 (DDR) 缺陷或复制应激驱动.
- DDR缺陷导致遗传改变,推动癌细胞的进化.
- 这些漏洞为精准医学提供了治疗目标.
研究的目的:
- 提供针对利用DNA损伤反应 (DDR) 途径的向抗瘤疗法的进展概述.
- 讨论这些疗法对未来癌症治疗策略的影响.
主要方法:
- 关于DDR向治疗的最新研究的回顾.
- 分析治疗策略,包括PARP抑制剂和激酶抑制剂.
- 探索生物标志物发育和耐药机制.
主要成果:
- PARP 抑制剂 (例如,Olaparib) 通过合成致死性在具有 DDR 缺陷 (例如,BRCA 突变) 的癌症中表现出有效性.
- 开发针对关键DDR组件 (DNA-PK,ATM,ATR,Chk1,Chk2,Wee1) 的抑制剂.
- 目前正在进行的研究重点是预测生物标志物,耐药性机制和组合疗法.
结论:
- 准DDR途径是癌症治疗的一个有希望的策略.
- 优化DDR向疗法包括生物标志物开发,理解耐药性和组合方法.
- 这些进步具有显著的潜力,可以改善瘤学患者的治疗结果.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
3.9K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Overview of DNA Repair
30.9K
In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Chemically...
30.9K
DNA Damage Can Stall the Cell Cycle
2.6K
2.6K
